January 22, 2026
177
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
3:22Now PlayingOn this episode of Stock Movers:
- Corcept Therapeutic (CORT) shares soar after the pharmaceutical firm said its Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in platinum-resistant ovarian cancer met its overall survival primary endpoint, showing a 35% reduction in death risk compared to nab-paclitaxel alone.
- Abbott Labs (ABT) shares sink after the medical devices firm forecasted first-quarter earnings that fell short of estimates. The company also reported organic sales for the fourth quarter that missed Wall Street’s estimates.
- Arista Networks (ANET) shares jump. The company has been a beneficiary of AI-related spending, rising more than 370% since the end of 2022. Piper Sandler upgraded the stock earlier this month.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Corcept Therapeutic Soars, Abbott Labs Sinks, Arista Networks Jumps on AI Spending
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.